Literature DB >> 32339374

Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD.

Shuo Y Ma1,2, Ke S Sun1,2, Miao Zhang1,2, Xia Zhou1,2, Xiao H Zheng1,2, Si Y Tian1,2, Yan S Liu1,2, Ling Chen3, Xing Gao4, Jing Ye4, Xin M Zhou1,2, Jing B Wang1,2, Ying Han1,2.   

Abstract

BACKGROUND & AIMS: The pathological hallmark of nonalcoholic fatty liver disease (NAFLD) is an imbalance in hepatic lipid homeostasis, in which lipophagy has been found to play a vital role. However, the underlying molecular mechanisms remain unclear. We investigated the role of chaperone-mediated autophagy (CMA) in the pathogenesis of NAFLD.
METHODS: CMA activity was evaluated in liver tissues from NAFLD patients and high-fat diet (HFD)-fed mice. Liver-specific LAMP2A-knockout mice and HepG2 cells lacking LAMP2A [L2A(-) cells] were used to investigate the influence of CMA on lipolysis in hepatocytes. The expression of Plin5, a lipid droplet (LD)-related protein, was also evaluated in human and mouse liver tissues and in [L2A(-)] cells.
RESULTS: Here, we found disrupted CMA function in the livers of NAFLD patients and animal models, displaying obvious reduction of LAMP2A and concurrent with decreased levels of CMA-positive regulators. More LDs and higher serum triglycerides accumulated in liver-specific LAMP2A-knockout mice and L2A(-) cells under high-fat challenge. Meanwhile, deleting LAMP2A hindered LD breakdown but not increased LD formation. In addition, the LD-associated protein Plin5 is a CMA substrate, and its degradation through CMA is required for LD breakdown.
CONCLUSIONS: We propose that the disruption of CMA-induced Plin5 degradation obstacles LD breakdown, explaining the lipid homeostasis imbalance in NAFLD.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NAFLD; chaperone-mediated autophagy; lipolysis; perilipin 5

Mesh:

Substances:

Year:  2020        PMID: 32339374     DOI: 10.1111/liv.14492

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  14 in total

1.  Lipophagy at a glance.

Authors:  Micah B Schott; Cody N Rozeveld; Shaun G Weller; Mark A McNiven
Journal:  J Cell Sci       Date:  2022-03-09       Impact factor: 5.235

Review 2.  The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Aldo Grefhorst; Ivo P van de Peppel; Lars E Larsen; Johan W Jonker; Adriaan G Holleboom
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-01       Impact factor: 5.555

Review 3.  Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions.

Authors:  Claudio M Fader Kaiser; Patricia S Romano; M Cristina Vanrell; Cristian A Pocognoni; Julieta Jacob; Benjamín Caruso; Laura R Delgui
Journal:  Front Cell Dev Biol       Date:  2022-02-07

4.  Sphingomyelin phosphodiesterase acid like 3B (SMPDL3b) regulates Perilipin5 (PLIN5) expression and mediates lipid droplet formation.

Authors:  Shamroop Kumar Mallela; Mengyuan Ge; Judith Molina; Javier Varona Santos; Jin-Ju Kim; Alla Mitrofanova; Hassan Al-Ali; Brian Marples; Sandra Merscher; Alessia Fornoni
Journal:  Genes Dis       Date:  2022-02-03

5.  D-Cysteine Activates Chaperone-Mediated Autophagy in Cerebellar Purkinje Cells via the Generation of Hydrogen Sulfide and Nrf2 Activation.

Authors:  Erika Ueda; Tomoko Ohta; Ayumu Konno; Hirokazu Hirai; Yuki Kurauchi; Hiroshi Katsuki; Takahiro Seki
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

6.  The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity.

Authors:  Flaminia Ferri; Simone Carotti; Guido Carpino; Monica Mischitelli; Alfredo Cantafora; Antonio Molinaro; Maria Eva Argenziano; Simona Parisse; Alessandro Corsi; Mara Riminucci; Quirino Lai; Gianluca Mennini; Gustavo Spadetta; Francesco Pugliese; Massimo Rossi; Sergio Morini; Eugenio Gaudio; Stefano Ginanni Corradini
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 7.  Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights.

Authors:  Paola Berenice Mass Sanchez; Marinela Krizanac; Ralf Weiskirchen; Anastasia Asimakopoulos
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

Review 8.  Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.

Authors:  Douglas G Mashek
Journal:  Mol Metab       Date:  2020-11-10       Impact factor: 7.422

9.  Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.

Authors:  Yan Huang; Qinyi Gan; Rongtao Lai; Weijing Wang; Simin Guo; Zike Sheng; Lu Chen; Qing Guo; Wei Cai; Hui Wang; Gangde Zhao; Zhujun Cao; Qing Xie
Journal:  Front Cell Infect Microbiol       Date:  2022-01-17       Impact factor: 5.293

Review 10.  The ménage à trois of autophagy, lipid droplets and liver disease.

Authors:  Yasmina Filali-Mouncef; Catherine Hunter; Federica Roccio; Stavroula Zagkou; Nicolas Dupont; Charlotte Primard; Tassula Proikas-Cezanne; Fulvio Reggiori
Journal:  Autophagy       Date:  2021-04-02       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.